Fermenta Biotec.

{
  "main_header": {
    "sid": 261671,
    "name": "Fermenta Biotec.",
    "stock_name": "Fermenta Biotec.",
    "full_name": "Fermenta Biotech Ltd",
    "name_url": "stocks-analysis/fermenta-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "310.35",
    "chg": -17.2,
    "chgp": "-5.25%",
    "dir": -1,
    "prev_price": "327.55",
    "mcapval": "912.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506414,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE225B01021",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "1.24 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fermenta-biotec-261671-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Fermenta Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-is-rated-sell-3830608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FermentaBiotech_mojoScore_3830608.png",
        "date": "2026-02-10 10:10:07",
        "description": "Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Fermenta Biotech Ltd Reports Sharp Quarterly Decline Amid Negative Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-reports-sharp-quarterly-decline-amid-negative-financial-trend-3829442",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FermentaBiotech_fintrenddot_3829442.png",
        "date": "2026-02-10 08:00:11",
        "description": "Fermenta Biotech Ltd has experienced a notable reversal in its recent financial trajectory, with the December 2025 quarter marking a downturn in key performance metrics. Despite robust nine-month growth figures, the latest quarter reveals contraction in sales and profitability, prompting a downgrade in the company’s mojo grade to Sell from Hold."
      },
      {
        "title": "Are Fermenta Biotech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-fermenta-biotech-ltd-latest-results-good-or-bad-3829063",
        "imagepath": "",
        "date": "2026-02-09 19:16:16",
        "description": "Fermenta Biotech Ltd's latest financial results for Q3 FY26 indicate a notable shift in performance compared to previous periods. The company reported a net profit of ₹14.19 crore, reflecting a significant decline of 24.83% quarter-on-quarter (QoQ) and 24.70% year-on-year (YoY). Similarly, net sales for the quarter amounted to ₹137.36 crore, which is down 12.21% QoQ. \n\nThe operating margin, excluding other income, decreased to 18.17%, marking the lowest level in recent quarters and indicating potential operational challenges. Despite these declines, the company maintains a strong return on equity (ROE) of 28.66%, suggesting effective capital efficiency relative to its shareholder equity base.\n\nThe nine-month cumulative performance for FY26 remains respectable, with a net profit of ₹54.08 crore, which is up 27.34% YoY. However, the sharp sequential decline in Q3 raises concerns regarding the sustainability o..."
      },
      {
        "title": "Fermenta Biotech Q3 FY26: Growth Momentum Stalls as Margins Contract Sharply",
        "link": "https://www.marketsmojo.com/news/result-analysis/fermenta-biotech-q3-fy26-growth-momentum-stalls-as-margins-contract-sharply-3829009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/FermentaBiotech_quaterlyResult_3829009.png",
        "date": "2026-02-09 18:00:53",
        "description": "Fermenta Biotech Limited, a mid-sized pharmaceutical and biotechnology company with a market capitalisation of ₹977.00 crores, has reported concerning quarterly results that signal a sharp reversal in the strong momentum witnessed earlier in FY2026. The company's consolidated net profit for Q3 FY26 stood at ₹14.19 crores, plummeting 24.83% quarter-on-quarter and declining 24.70% year-on-year, marking the weakest quarterly performance in recent periods. The stock, trading at ₹326.50 as of February 09, 2026, has declined 0.53% following the results announcement, reflecting investor disappointment with the deteriorating operational metrics."
      },
      {
        "title": "When is the next results date for Fermenta Biotech Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-fermenta-biotech-ltd-3819146",
        "imagepath": "",
        "date": "2026-02-03 23:17:05",
        "description": "The next results date for Fermenta Biotech Ltd is scheduled for 09 February 2026...."
      },
      {
        "title": "Fermenta Biotech Gains 3.53%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-gains-353-3-key-factors-driving-the-weeks-momentum-3814274",
        "imagepath": "",
        "date": "2026-02-01 11:01:10",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock rises 1.98% to Rs.317.45 amid positive market sentiment</p>\n                    <p><strong>Jan 29:</strong> Golden Cross formation signals potential bullish breakout</p>\n                    <p><strong>Jan 30:</strong> MarketsMOJO upgrades rating to Hold; stock rebounds 3.92% to Rs.322.30</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.311.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.322.30</div><div class=\"stat-change positive\">+3.53%</div></div>\n      ..."
      },
      {
        "title": "Fermenta Biotech Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotech-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financial-signals-3810715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/FermentaBiotech_mojoScore_3810715.png",
        "date": "2026-01-30 08:07:11",
        "description": "Fermenta Biotech Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, robust quarterly financial performance, and attractive valuation metrics. Despite recent price weakness, the company’s fundamentals and technical outlook have shifted positively, prompting a reassessment of its market stance."
      },
      {
        "title": "Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-ltd-technical-momentum-shifts-amid-mixed-market-signals-3810550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/FermentaBiotech_technicaldot_3810550.png",
        "date": "2026-01-30 08:00:40",
        "description": "Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite recent price declines. The company’s technical indicators present a complex picture, with weekly signals generally positive while monthly metrics remain cautious. This nuanced outlook comes amid a broader market environment where Fermenta’s performance continues to lag the Sensex over short and medium terms, though it boasts impressive long-term returns."
      },
      {
        "title": "Why is Fermenta Biotech Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotech-ltd-fallingrising-3810382",
        "imagepath": "",
        "date": "2026-01-30 00:51:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Fermenta Biotech’s stock has underperformed relative to the broader market and its sector peers over multiple time frames. In the past week, the stock declined by 4.08%, while the Sensex gained 0.31%. Over the last month, the stock’s fall of 11.51% significantly outpaced the Sensex’s modest 2.51% decline. Year-to-date, the stock is down 10.43%, compared to a 3.11% drop in the benchmark index. The one-year performance is particularly stark, with Fermenta Biotech’s shares falling 14.63% even as the Sensex rose by 7.88%. These figures highlight a persistent weakness in the stock despite broader market gains.</p>\n<p>On the day of the decline, the stock reversed a two-day rally, hitting an intraday low of ₹305.25, representing a 5.58% drop ..."
      }
    ],
    "total": 529,
    "sid": "261671",
    "stock_news_url": "https://www.marketsmojo.com/news/fermenta-biotech-261671"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Results For Quarter And Nine Months Ended December 31 2025.",
      "datetime": "02-Feb-2026",
      "details": "Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve unaudited financial results (standalone and consolidated) for quarter and nine months ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "21-Jan-2026",
      "details": "Certificate under Reg. 74(5) for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order",
      "datetime": "31-Dec-2025",
      "details": "Intimation of order received from Central Goods & Services Tax - Mandi Division",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has declared <strong>50%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>5:5</strong> stock split, ex-date: 08 Aug 18",
          "dt": "2018-08-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 13 Feb 20",
          "dt": "2020-02-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Fermenta Biotech Ltd is Rated Sell

2026-02-10 10:10:07

Fermenta Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Fermenta Biotech Ltd Reports Sharp Quarterly Decline Amid Negative Financial Trend

2026-02-10 08:00:11

Fermenta Biotech Ltd has experienced a notable reversal in its recent financial trajectory, with the December 2025 quarter marking a downturn in key performance metrics. Despite robust nine-month growth figures, the latest quarter reveals contraction in sales and profitability, prompting a downgrade in the company’s mojo grade to Sell from Hold.

Read full news article

Are Fermenta Biotech Ltd latest results good or bad?

2026-02-09 19:16:16

Fermenta Biotech Ltd's latest financial results for Q3 FY26 indicate a notable shift in performance compared to previous periods. The company reported a net profit of ₹14.19 crore, reflecting a significant decline of 24.83% quarter-on-quarter (QoQ) and 24.70% year-on-year (YoY). Similarly, net sales for the quarter amounted to ₹137.36 crore, which is down 12.21% QoQ. The operating margin, excluding other income, decreased to 18.17%, marking the lowest level in recent quarters and indicating potential operational challenges. Despite these declines, the company maintains a strong return on equity (ROE) of 28.66%, suggesting effective capital efficiency relative to its shareholder equity base. The nine-month cumulative performance for FY26 remains respectable, with a net profit of ₹54.08 crore, which is up 27.34% YoY. However, the sharp sequential decline in Q3 raises concerns regarding the sustainability o...

Read full news article

Fermenta Biotech Q3 FY26: Growth Momentum Stalls as Margins Contract Sharply

2026-02-09 18:00:53

Fermenta Biotech Limited, a mid-sized pharmaceutical and biotechnology company with a market capitalisation of ₹977.00 crores, has reported concerning quarterly results that signal a sharp reversal in the strong momentum witnessed earlier in FY2026. The company's consolidated net profit for Q3 FY26 stood at ₹14.19 crores, plummeting 24.83% quarter-on-quarter and declining 24.70% year-on-year, marking the weakest quarterly performance in recent periods. The stock, trading at ₹326.50 as of February 09, 2026, has declined 0.53% following the results announcement, reflecting investor disappointment with the deteriorating operational metrics.

Read full news article

When is the next results date for Fermenta Biotech Ltd?

2026-02-03 23:17:05

The next results date for Fermenta Biotech Ltd is scheduled for 09 February 2026....

Read full news article

Fermenta Biotech Gains 3.53%: 3 Key Factors Driving the Week’s Momentum

2026-02-01 11:01:10

Key Events This Week

Jan 27: Stock rises 1.98% to Rs.317.45 amid positive market sentiment

Jan 29: Golden Cross formation signals potential bullish breakout

Jan 30: MarketsMOJO upgrades rating to Hold; stock rebounds 3.92% to Rs.322.30

Week Open

Rs.311.30

Week Close

Rs.322.30

+3.53%

...

Read full news article

Fermenta Biotech Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Signals

2026-01-30 08:07:11

Fermenta Biotech Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, robust quarterly financial performance, and attractive valuation metrics. Despite recent price weakness, the company’s fundamentals and technical outlook have shifted positively, prompting a reassessment of its market stance.

Read full news article

Fermenta Biotech Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-30 08:00:40

Fermenta Biotech Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, despite recent price declines. The company’s technical indicators present a complex picture, with weekly signals generally positive while monthly metrics remain cautious. This nuanced outlook comes amid a broader market environment where Fermenta’s performance continues to lag the Sensex over short and medium terms, though it boasts impressive long-term returns.

Read full news article

Why is Fermenta Biotech Ltd falling/rising?

2026-01-30 00:51:37

Recent Price Movement and Market Context

Fermenta Biotech’s stock has underperformed relative to the broader market and its sector peers over multiple time frames. In the past week, the stock declined by 4.08%, while the Sensex gained 0.31%. Over the last month, the stock’s fall of 11.51% significantly outpaced the Sensex’s modest 2.51% decline. Year-to-date, the stock is down 10.43%, compared to a 3.11% drop in the benchmark index. The one-year performance is particularly stark, with Fermenta Biotech’s shares falling 14.63% even as the Sensex rose by 7.88%. These figures highlight a persistent weakness in the stock despite broader market gains.

On the day of the decline, the stock reversed a two-day rally, hitting an intraday low of ₹305.25, representing a 5.58% drop ...

Read full news article

View All News